Changes in viral hepatitis B screening practices over time in West African HIV clinics

We aimed to describe changes in hepatitis B screening practices over a 3-year period among HIV-infected patients in West Africa. A medical chart review was conducted in urban HIV treatment centers in Ivory Coast (3 sites), Benin, Burkina Faso, Senegal, and Togo (1 site each). Among patients who star...

Full description

Saved in:
Bibliographic Details
Published in:Médecine et maladies infectieuses 2017-10, Vol.47 (6), p.394-400
Main Authors: Coffie, P.A., Patassi, A., Doumbia, A., Bado, G., Messou, E., Minga, A., Allah-Kouadio, E., Zannou, D.M., Seydi, M., Kakou, A.R., Dabis, F., Wandeler, G.
Format: Article
Language:English
Subjects:
Adult
Africa, Western - epidemiology
Afrique subsaharienne
Alanine Transaminase - blood
Anti-Retroviral Agents - administration & dosage
Antiretroviral agents
CD4 Lymphocyte Count
Confidence intervals
Demographics
Dépistage
Female
HBV
Hepatitis
Hepatitis B
Hepatitis B - complications
Hepatitis B - diagnosis
Hepatitis B - epidemiology
Hepatitis B surface antigen
Hepatitis B Surface Antigens - blood
HIV
HIV Infections - complications
HIV Infections - drug therapy
HIV-1 - isolation & purification
HIV-2 - isolation & purification
HIV-infected patients
Human immunodeficiency virus
Humans
Male
Mass Screening - trends
Medical screening
Medical treatment
Middle Aged
Patients
Patients infectés par le VIH
Prevalence
Regression analysis
Retrospective Studies
Risk Factors
Screening
Statistical analysis
Sub-Saharan Africa
Surveys and Questionnaires
Tenofovir
VHB
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We aimed to describe changes in hepatitis B screening practices over a 3-year period among HIV-infected patients in West Africa. A medical chart review was conducted in urban HIV treatment centers in Ivory Coast (3 sites), Benin, Burkina Faso, Senegal, and Togo (1 site each). Among patients who started antiretroviral treatment between 2010 and 2012, 100 per year were randomly selected from each clinic. Demographic, clinical, and laboratory data was collected using a standardized questionnaire. We assessed changes in the proportion of patients screened over time and identified predictors of screening in a multivariable logistic regression. A total of 2097 patients were included (median age: 37 years, 65.4% of women). Overall, 313 (14.9%) patients had been screened for hepatitis B, with an increase from 10.6% in 2010 to 18.9% in 2012 (P
ISSN:0399-077X
1769-6690
DOI:10.1016/j.medmal.2017.04.011